Impact of DNA-based Risk Assessments on Smoking Cessation in Crohn's Disease
Author Information
Author(s): Whitwell Sophia CL, Mathew Christopher G, Lewis Cathryn M, Forbes Alastair, Watts Sally, Sanderson Jeremy, Hollands Gareth J, Prevost A Toby, Armstrong David, Kinmonth Ann Louise, Sutton Stephen, Marteau Theresa M
Primary Institution: King's College London
Hypothesis
Smokers who are first degree relatives (FDRs) of CD probands are more likely to make smoking cessation attempts following communication of risk estimates of developing CD that incorporate DNA analysis, compared with an equivalent communication that does not incorporate DNA analysis.
Conclusion
The study aims to assess whether communicating DNA-based risk assessments can motivate smokers who are relatives of Crohn's disease patients to quit smoking.
Supporting Evidence
- Smoking doubles the risk of developing Crohn's disease.
- First degree relatives of Crohn's disease patients have a twenty-fold increased risk of developing the condition.
- Communicating DNA-based risk assessments may motivate behavior change.
Takeaway
The study is trying to see if telling smokers about their DNA risk for Crohn's disease will help them stop smoking.
Methodology
A parallel groups randomised controlled trial with smokers who are FDRs of probands with CD, comparing DNA-based risk assessment with non-DNA risk assessment.
Potential Biases
Potential bias in self-reported smoking cessation and the influence of personal beliefs about DNA results.
Limitations
The study may not account for all factors influencing smoking cessation and relies on self-reported data.
Participant Demographics
Participants are smokers aged 18 and over, who are first degree relatives of Crohn's disease probands.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website